DARE logo

Dare Bioscience (DARE) Free Cash Flow

Annual FCF

-$39.49 M
-$21.33 M-117.54%

December 31, 2023

Summary

Performance

1-Year Change

-117.54%

3-Year Change

-56.37%

5-Year Change

-284.09%

15-Year Change

-1454.51%

DARE Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

35.52%
DARE annual free cash flow is higher than 35.52% of companies in Healthcare sector

High & Low

All-time High

-$372.30 K

3-Year Low

-$39.49 M
DARE annual free cash flow is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
DARE previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 28, 2025
DARE next annual earnings announcement is scheduled for Mar 28, 2025

OtherDAREcash flowmetrics:

Annual CFO

-$38.86 M
DARE annual cash flow from operations is -$38.86 million

Annual CFF

$15.64 M
DARE annual cash flow from financing activities is $15.64 million

Annual CFI

-$629.40 K
DARE annual cash flow from investing activities is -$629.40 thousand

Annual CAPEX

$629.40 K
DARE annual capital expenditures is $629.40 thousand

Quarterly FCF

-$5.64 M
-$18.26 M-144.71%

September 30, 2024

Summary

Performance

3-Month Change

-144.71%

1-Year Change

+35.79%

3-Year Change

+65%

5-Year Change

+65%

DARE Quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

45.43%
DARE quarterly free cash flow is higher than 45.43% of companies in Healthcare sector

High & Low

All-time High

$24.77 M
DARE quarterly free cash flow is currently -122.78% below its historical high of $24.77 million

3-Year Low

-$16.12 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
DARE previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 28, 2025
DARE next earnings announcement is scheduled for Mar 28, 2025

OtherDAREcash flowmetrics:

Quarterly CFO

-$5.92 M
DARE quarterly cash flow from operations is -$5.92 million

Quarterly CFF

$436.40 K
DARE quarterly cash flow from financing activities is $436.40 thousand

Quarterly CFI

$282.30 K
DARE quarterly cash flow from investing activities is $282.30 thousand

Quarterly CAPEX

-$282.30 K
DARE quarterly capital expenditures is -$282.30 thousand

TTM FCF

-$8.63 M
+$2.35 M+21.43%

September 30, 2024

Summary

Performance

3-Month Change

+21.43%

1-Year Change

+78.15%

3-Year Change

+60.64%

5-Year Change

+60.64%

DARE TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

64.66%
DARE TTM free cash flow is higher than 64.66% of companies in Healthcare sector

High & Low

All-time High

$24.44 M
DARE TTM free cash flow is currently -135.31% below its historical high of $24.44 million

3-Year Low

-$39.49 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
DARE previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 28, 2025
DARE next earnings announcement is scheduled for Mar 28, 2025

OtherDAREcash flowmetrics:

TTM CFO

-$8.01 M
DARE TTM cash flow from operations is -$8.01 million

TTM CFF

$5.88 M
DARE TTM cash flow from financing activities is $5.88 million

TTM CFI

-$617.50 K
DARE TTM cash flow from investing activities is -$617.50 thousand

TTM CAPEX

$617.50 K
DARE TTM capital expenditures is $617.50 thousand

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

Annual FCF

-$39.49 M
DARE annual free cash flow is -$39.49 million

Annual CFO

-$38.86 M
DARE annual cash flow from operations is -$38.86 million

Annual CAPEX

$629.40 K
DARE annual capital expenditures is $629.40 thousand

DARE Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-117.5%+35.8%+78.2%
3 y3 years-56.4%+65.0%+60.6%
5 y5 years-284.1%+65.0%+60.6%

DARE Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-117.5%at low-144.7%+65.0%at high+78.2%
5 y5-year-196.5%at low-144.7%+65.0%at high+78.2%
alltimeall time<-9999.0%at low-122.8%+65.0%-135.3%+79.1%

Dare Bioscience Free Cash Flow History

DateAnnualQuarterlyTTM
Sep 2024
-
-$5.64 M(-144.7%)
-$8.63 M(-21.4%)
Jun 2024
-
$12.62 M(-285.0%)
-$10.98 M(-63.6%)
Mar 2024
-
-$6.82 M(-22.4%)
-$30.19 M(-23.5%)
Dec 2023
-$39.49 M(+117.5%)
-$8.79 M(+9.9%)
-$39.49 M(+7.9%)
Sep 2023
-
-$8.00 M(+21.4%)
-$36.60 M(+82.5%)
Jun 2023
-
-$6.59 M(-59.1%)
-$20.06 M(-8.5%)
Mar 2023
-
-$16.12 M(+173.2%)
-$21.92 M(+20.8%)
Dec 2022
-$18.15 M(-36.9%)
-$5.90 M(-169.0%)
-$18.15 M(-18.1%)
Sep 2022
-
$8.55 M(-201.1%)
-$22.17 M(-24.6%)
Jun 2022
-
-$8.45 M(-31.6%)
-$29.41 M(-10.2%)
Mar 2022
-
-$12.35 M(+24.5%)
-$32.75 M(+13.8%)
Dec 2021
-$28.78 M(+14.0%)
-$9.92 M(-859.4%)
-$28.78 M(+2.6%)
Sep 2021
-
$1.31 M(-111.1%)
-$28.06 M(-19.2%)
Jun 2021
-
-$11.79 M(+40.8%)
-$34.72 M(+28.4%)
Mar 2021
-
-$8.38 M(-8.9%)
-$27.03 M(+7.0%)
Dec 2020
-$25.25 M(+89.6%)
-$9.20 M(+71.7%)
-$25.25 M(+27.1%)
Sep 2020
-
-$5.36 M(+30.6%)
-$19.87 M(+12.3%)
Jun 2020
-
-$4.10 M(-37.8%)
-$17.69 M(+6.5%)
Mar 2020
-
-$6.60 M(+73.2%)
-$16.60 M(+24.7%)
Dec 2019
-$13.32 M(+29.5%)
-$3.81 M(+19.8%)
-$13.32 M(+9.0%)
Sep 2019
-
-$3.18 M(+5.4%)
-$12.22 M(+3.6%)
Jun 2019
-
-$3.02 M(-8.8%)
-$11.79 M(+2.8%)
Mar 2019
-
-$3.31 M(+22.1%)
-$11.47 M(+11.6%)
Dec 2018
-$10.28 M
-$2.71 M(-1.6%)
-$10.28 M(+20.5%)
DateAnnualQuarterlyTTM
Sep 2018
-
-$2.75 M(+2.1%)
-$8.53 M(+18.6%)
Jun 2018
-
-$2.70 M(+27.3%)
-$7.20 M(+56.1%)
Mar 2018
-
-$2.12 M(+120.5%)
-$4.61 M(+81.4%)
Dec 2017
-$2.54 M(+582.3%)
-$961.10 K(-32.3%)
-$2.54 M(+45.5%)
Sep 2017
-
-$1.42 M(+1194.6%)
-$1.75 M(-107.1%)
Jun 2017
-
-$109.60 K(+116.6%)
$24.44 M(+85.2%)
Mar 2017
-
-$50.60 K(-69.7%)
$13.20 M(-3644.5%)
Dec 2016
-$372.30 K(-98.8%)
-$167.00 K(-100.7%)
-$372.30 K(-95.6%)
Sep 2016
-
$24.77 M(-318.1%)
-$8.55 M(-79.3%)
Jun 2016
-
-$11.35 M(-16.6%)
-$41.32 M(+9.2%)
Mar 2016
-
-$13.62 M(+63.2%)
-$37.84 M(+17.5%)
Dec 2015
-$32.19 M(+66.9%)
-$8.35 M(+4.3%)
-$32.19 M(+8.9%)
Sep 2015
-
-$8.00 M(+1.6%)
-$29.56 M(+8.7%)
Jun 2015
-
-$7.88 M(-1.2%)
-$27.20 M(+15.4%)
Mar 2015
-
-$7.97 M(+39.4%)
-$23.58 M(+22.2%)
Dec 2014
-$19.29 M(+16.0%)
-$5.72 M(+1.4%)
-$19.29 M(+14.5%)
Sep 2014
-
-$5.64 M(+32.5%)
-$16.84 M(+16.7%)
Jun 2014
-
-$4.25 M(+15.6%)
-$14.43 M(-8.1%)
Mar 2014
-
-$3.68 M(+12.5%)
-$15.70 M(-5.6%)
Dec 2013
-$16.62 M(-21.5%)
-$3.27 M(+1.5%)
-$16.62 M(+24.5%)
Sep 2013
-
-$3.22 M(-41.7%)
-$13.35 M(+31.8%)
Jun 2013
-
-$5.52 M(+20.0%)
-$10.13 M(+120.0%)
Mar 2013
-
-$4.60 M
-$4.60 M
Dec 2012
-$21.18 M
-
-

FAQ

  • What is Dare Bioscience annual free cash flow?
  • What is the all time high annual FCF for Dare Bioscience?
  • What is Dare Bioscience annual FCF year-on-year change?
  • What is Dare Bioscience quarterly free cash flow?
  • What is the all time high quarterly FCF for Dare Bioscience?
  • What is Dare Bioscience quarterly FCF year-on-year change?
  • What is Dare Bioscience TTM free cash flow?
  • What is the all time high TTM FCF for Dare Bioscience?
  • What is Dare Bioscience TTM FCF year-on-year change?

What is Dare Bioscience annual free cash flow?

The current annual FCF of DARE is -$39.49 M

What is the all time high annual FCF for Dare Bioscience?

Dare Bioscience all-time high annual free cash flow is -$372.30 K

What is Dare Bioscience annual FCF year-on-year change?

Over the past year, DARE annual free cash flow has changed by -$21.33 M (-117.54%)

What is Dare Bioscience quarterly free cash flow?

The current quarterly FCF of DARE is -$5.64 M

What is the all time high quarterly FCF for Dare Bioscience?

Dare Bioscience all-time high quarterly free cash flow is $24.77 M

What is Dare Bioscience quarterly FCF year-on-year change?

Over the past year, DARE quarterly free cash flow has changed by +$3.14 M (+35.79%)

What is Dare Bioscience TTM free cash flow?

The current TTM FCF of DARE is -$8.63 M

What is the all time high TTM FCF for Dare Bioscience?

Dare Bioscience all-time high TTM free cash flow is $24.44 M

What is Dare Bioscience TTM FCF year-on-year change?

Over the past year, DARE TTM free cash flow has changed by +$30.86 M (+78.15%)